IBRX (ImmunityBio) pre-market: Q4 2025 results Mar 3, 2026 could move stock
IBRX stock pre-market note: ImmunityBio reports Q4 and FY2025 results Mar 3, 2026; key pipeline data may shift price
IBRX stock pre-market note: ImmunityBio reports Q4 and FY2025 results Mar 3, 2026; key pipeline data may shift price
RBC maintains Outperform on uniQure; QURE analyst rating review and investor implications, Feb 2026
Needham maintains Buy on Teleflex (TFX) and raises PT to $147. TFX analyst rating updates and implications for investors
After hours oversold bounce analysis of HEMACEM.BO stock; price INR 50.88, volume 564.00, model forecast and Meyka grade
AFME.PA stock surged to €3.62 intraday on EURONEXT 02 Mar 2026; high volume and analyst metrics warrant close monitoring
Coles share price falls as H1 profit slips 11.3% to $511m while the 41c interim dividend rises. We assess valuation, UBS’s $24 target, and key watch items for ASX futures.
Intraday oversold bounce on BMY.SW stock at CHF42.54; short-term trade plan, targets and risks
7386.T stock near JPY 3345.00 on 02 Mar 2026; oversold bounce setup with short-term target JPY 4,100.00
0299.HK stock at HKD 0.106 on 02 Mar 2026; oversold bounce watch with Meyka AI forecast and price targets
Ahmadinejad death rumor denied; BTCUSD watches headline-driven volatility. For Japan investors, Iran-Israel tensions may add a short-lived geopolitical risk premium. Practical trading steps inside.